MedTrace Logo

Stereotactic Radiosurgery in Treating Patients With Brain Tumors

NCT00019578 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2023-10-31

No results posted yet for this study

Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE: Phase I trial to study the effectiveness of stereotactic radiosurgery in treating patients who have brain tumors.

Conditions

  • Adult Central Nervous System Germ Cell Tumor
  • Adult Malignant Meningioma
  • Adult Medulloblastoma
  • Adult Noninfiltrating Astrocytoma
  • Adult Oligodendroglioma
  • Adult Craniopharyngioma
  • Adult Meningioma
  • Brain Metastases
  • Adult Ependymoma
  • Adult Pineal Parenchymal Tumor
  • Adult Brain Stem Glioma
  • Adult Infiltrating Astrocytoma
  • Mixed Gliomas
  • Stage IV Peripheral Primitive Neuroectodermal Tumor

Interventions

PROCEDURE

Sterotactic radiosurgery

Sponsors & Collaborators

  • National Institutes of Health Clinical Center (CC)

    lead NIH

Principal Investigators

  • Brian G. Fuller · National Cancer Institute (NCI)

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-11-30
Completion
2002-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00019578 on ClinicalTrials.gov